/ Minimally Invasive Procedures

Allergan Commemorates 25th Anniversary of the First Two Approved Uses of BOTOX® (onabotulinumtoxinA)

Allergan, Inc. (NYSE: AGN) today announced the launch of a video recognizing the physician pioneers and patient communities who contributed to the development of BOTOX® (onabotulinumtoxinA), one of the most recognized pharmaceutical brands in the United States. The video kicks off a year-long campaign to commemorate the 25th anniversary of the first approved uses of BOTOX® and to honor its heritage as a medical advancement.

5664 video views since 5/9/2014